Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel.

Date publication

février 2017

Journal

The British journal of dermatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr CRIBIER Bernard

Tous les auteurs :
Schaller M, Almeida LM, Bewley A, Cribier B, Dlova NC, Kautz G, Mannis M, Oon HH, Rajagopalan M, Steinhoff M, Thiboutot D, Troielli P, Webster G, Wu Y, van Zuuren E, Tan J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/27861741

Résumé

Rosacea is currently treated according to subtypes. As this does not adequately address the spectrum of clinical presentation (phenotypes), it has implications for patient management. The ROSacea COnsensus panel was established to address this issue.

Mots clés

Algorithms, Consensus, Cosmeceuticals, therapeutic use, Dermatologic Agents, therapeutic use, Drug Therapy, Combination, Eye Diseases, drug therapy, Humans, Rosacea, drug therapy, Skin Care, methods, Sunscreening Agents, therapeutic use, Treatment Outcome

Référence

Br. J. Dermatol.. 2017 Feb;176(2):465-471